Litton Mark James 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Litton Mark James（CIK 1604834）在 2 家公司共报告 6 笔 SEC Form 4 内部人交易（最近一笔 2026-03-05）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-03-05 | LeonaBio, Inc. (LONA) | PRESIDENT and CEO | 买入 | 22,254 | $0 |
| 2026-03-05 | LeonaBio, Inc. (LONA) | PRESIDENT and CEO | 卖出 | 5,156 | $27,688 |
| 2026-01-05 | Athira Pharma, Inc. (ATHA) | President and CEO | 买入 | 10,834 | $0 |
| 2026-01-05 | Athira Pharma, Inc. (ATHA) | President and CEO | 卖出 | 2,586 | $17,792 |
| 2025-07-02 | Athira Pharma, Inc. (ATHA) | President and CEO | 买入 | 108,334 | $0 |
| 2025-07-02 | Athira Pharma, Inc. (ATHA) | President and CEO | 卖出 | 25,123 | $7,286 |
来源：SEC Form 4 申报文件 · 截至 2026-03-05